<DOC>
	<DOC>NCT01655394</DOC>
	<brief_summary>IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.</brief_summary>
	<brief_title>Change of Nerve Conduction Properties in IVIg Dependent Neuropathies</brief_title>
	<detailed_description>IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored</detailed_description>
	<mesh_term>Guillain-Barre Syndrome</mesh_term>
	<criteria>immune neuropathy age above 18 y IVIg treatment exclusion: no IVIg treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>